Cargando…

18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment

PURPOSE: [18F] fluorodeoxyglucose positron emission tomography/computed tomography ([18F] FDG-PET/CT) is used for diagnosis, staging, response assessment and prognosis prediction in different tumors, but its role in esophageal cancer is still debated. The aim of this study was to evaluate the role o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krengli, Marco, Ferrara, Eleonora, Guaschino, Riccardo, Puta, Erinda, Turri, Lucia, Luciani, Ilaria, Sacchetti, Gian Mauro, Franco, Pierfrancesco, Brambilla, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016048/ https://www.ncbi.nlm.nih.gov/pubmed/35275345 http://dx.doi.org/10.1007/s12149-022-01733-9

Ejemplares similares

Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
por: Deantonio, Letizia, et al.
Publicado: (2018)

FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma
por: Krengli, Marco, et al.
Publicado: (2010)

FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma
por: Deantonio, Letizia, et al.
Publicado: (2008)

The role of activity, scan duration and patient’s body mass index in the optimization of FDG imaging protocols on a TOF-PET/CT scanner
por: Matheoud, Roberta, et al.
Publicado: (2021)

Influence of reconstruction settings on the performance of adaptive thresholding algorithms for FDG‐PET image segmentation in radiotherapy planning
por: Matheoud, Roberta, et al.
Publicado: (2011)

Running a Radiation Oncology Department at the Time of Coronavirus: An Italian Experience
por: Krengli, Marco, et al.
Publicado: (2020)

Running a Radiation Oncology Department at the Time of Coronavirus: An Italian Experience
por: Krengli, Marco, et al.
Publicado: (2020)

Correlation of [(18)F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma
por: Pisani, C., et al.
Publicado: (2021)

Staging of Primary Abdominal Lymphomas: Comparison of Whole-Body MRI with Diffusion-Weighted Imaging and (18)F-FDG-PET/CT
por: Stecco, Alessandro, et al.
Publicado: (2015)

Ultra-Hypofractionation for Whole-Breast Irradiation in Early Breast Cancer: Interim Analysis of a Prospective Study
por: Sigaudi, Valeria, et al.
Publicado: (2022)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer
por: Atsumi, Kazushige, et al.
Publicado: (2013)

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer
por: Kim, Nalee, et al.
Publicado: (2019)

Candida Esophagitis Incidentally Detected by 18F-FDG PET/CT in Metastatic Lung Adenocarcinoma
por: Martínez-Amador, N, et al.
Publicado: (2017)

Gross Tumor Delineation in Esophageal Cancer on MRI Compared With (18)F-FDG-PET/CT
por: Vollenbrock, Sophie E., et al.
Publicado: (2019)

Volumetric Evaluation of Staging (18)F-FDG PET/CT Images in Patients with Esophageal Cancer
por: Karahan Şen, Nazlı Pınar, et al.
Publicado: (2022)

[(18)F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging
por: Aiello, Marco, et al.
Publicado: (2020)

18-FDG PET in lung transplantation
por: Algieri, I, et al.
Publicado: (2015)

Myocarditis on (18)FDG-PET imaging
por: Chaaban, Nourhan, et al.
Publicado: (2022)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

Imaging Features of Breast Dermatofibrosarcoma Protuberans in Various Modalities Including FDG-PET CT
por: Bae, Suk Hyun, et al.
Publicado: (2016)

Impact of (18)F-FDG PET, PET/CT, and PET/MRI on Staging and Management as an Initial Staging Modality in Breast Cancer: A Systematic Review and Meta-analysis
por: Han, Sangwon, et al.
Publicado: (2021)

(18)F-FDG PET/CT is an ideal imaging modality for the early diagnosis of relapsing polychondritis: A case report
por: Wang, JianJie, et al.
Publicado: (2017)

(18)F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer
por: Mantziari, Styliani, et al.
Publicado: (2020)

Candida esophagitis incidentally detected by 18F‐FDG PET/CT in a patient with CNS lymphoma
por: Bayar, Melikşah, et al.
Publicado: (2021)

Identification of (18)F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal Cancer
por: Galvez, Thierry, et al.
Publicado: (2023)

Depressive symptoms in amnesic mild cognitive impairment: an FDG-PET/CT study
por: Mauri, Marco, et al.
Publicado: (2022)

(18)F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis—A Multicenter Retrospective Study
por: Zattoni, Fabio, et al.
Publicado: (2019)

Capecitabine-Induced Ileitis during Neoadjuvant Pelvic Radio-Chemotherapy for Locally Advanced Rectal Cancer: A Case Report with Literature Review
por: Brignoli, Andrea, et al.
Publicado: (2023)

FDG avid pulmonary amyloid nodule in a patient with metastatic renal cell cancer on 18F-FDG PET/CT
por: Lee, Marco Enoch, et al.
Publicado: (2021)

PET probes beyond (18)F-FDG
por: Jiang, Lei, et al.
Publicado: (2014)

Feasibility of (18)FDG PET in the cardiac inflammation
por: Osiecki, Sebastian, et al.
Publicado: (2020)

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
por: Omloo, J. M. T., et al.
Publicado: (2011)

Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Esophageal Cancer Patients
por: Soydal, Çiğdem, et al.
Publicado: (2014)

Propensity score analysis of 18-FDG PET/CT-enhanced staging in patients undergoing surgery for esophageal cancer
por: Patel, N., et al.
Publicado: (2018)

Overexpression of METTL3 associated with the metabolic status on (18)F-FDG PET/CT in patients with Esophageal Carcinoma
por: Liu, Xu-Sheng, et al.
Publicado: (2020)

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Lee, Seokmo, et al.
Publicado: (2021)

Prognostic factors associated with (18)FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
por: Feng, Wei-Hsiang, et al.
Publicado: (2022)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Evaluation of Task-Related Brain Activity: Is There a Role for (18)F FDG-PET Imaging?
por: Chiaravalloti, Agostino, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j76esugqsqegra7gso0kp4lrgi